GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chimeric Therapeutics Ltd (OTCPK:CHMMF) » Definitions » Tax Rate %

CHMMF (Chimeric Therapeutics) Tax Rate % : -5.05% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Chimeric Therapeutics Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Chimeric Therapeutics's Tax Expense for the six months ended in Dec. 2024 was $0.09 Mil. Chimeric Therapeutics's Pre-Tax Income for the six months ended in Dec. 2024 was $-1.72 Mil. Therefore, Chimeric Therapeutics's Tax Rate % for the quarter that ended in Dec. 2024 was -5.05%.


Chimeric Therapeutics Tax Rate % Historical Data

The historical data trend for Chimeric Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chimeric Therapeutics Tax Rate % Chart

Chimeric Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Tax Rate %
- -1.13 -0.36 -0.08

Chimeric Therapeutics Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Tax Rate % Get a 7-Day Free Trial -0.89 0.09 -3.09 -0.56 -5.05

Chimeric Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Chimeric Therapeutics's Tax Rate % for the fiscal year that ended in Jun. 2024 is calculated as

Tax Rate %=Tax Expense (A: Jun. 2024 )/Pre-Tax Income (A: Jun. 2024 )
=0.007/-8.313
=-0.08 %

Chimeric Therapeutics's Tax Rate % for the quarter that ended in Dec. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Dec. 2024 )/Pre-Tax Income (Q: Dec. 2024 )
=0.087/-1.723
=-5.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chimeric Therapeutics Tax Rate % Related Terms

Thank you for viewing the detailed overview of Chimeric Therapeutics's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chimeric Therapeutics Business Description

Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells. Primary products under development by the company are NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company has one segment being the research, development and commercialization of health technologies.

Chimeric Therapeutics Headlines

From GuruFocus

Chimeric Therapeutics Ltd Investor Webinar Transcript

By GuruFocus Research 02-13-2024

Chimeric Therapeutics Ltd FNN Investor Event Transcript

By GuruFocus Research 02-13-2024